Cidara Therapeutics Inc.

18.93
-2.61 (-12.12%)
At close: Apr 01, 2025, 3:59 PM
18.92
-0.05%
After-hours: Apr 01, 2025, 04:40 PM EDT

Cidara Therapeutics Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20
Cash & Equivalents 189.82M 35.78M 32.73M 62.27M 35.91M
Short-Term Investments n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a
Other Long-Term Assets 96K 1.05M 634K 533K 2.02M
Receivables 1.69M 16.25M 5.83M 5.36M 11.18M
Inventory n/a 6.1M 1.00 -2.59M n/a
Other Current Assets 19.22M 2.73M 6.53M 2.59M 7.04M
Total Current Assets 210.74M 60.85M 45.09M 71.7M 57.19M
Property-Plant & Equipment 3.96M 5.13M 1.43M 2.54M 1.21M
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets 4.06M 6.17M 2.5M 3.63M 3.23M
Total Assets 214.8M 67.03M 47.59M 75.33M 60.42M
Account Payables 3.61M 3.77M 1.45M 1.3M 4.57M
Deferred Revenue n/a 25.09M 14.61M 13.92M 13.87M
Short-Term Debt 1.64M n/a n/a 3.74M 7.96M
Other Current Liabilities 44.3M 32.22M 19.21M 9.05M 7.02M
Total Current Liabilities 49.55M 67.42M 29.97M 34.02M 38.56M
Long-Term Debt 1.93M n/a n/a n/a n/a
Other Long-Term Liabilities n/a n/a n/a n/a n/a
Total Long-Term Liabilities 1.93M 7.82M 20.52M 19.73M 11.14M
Total Liabilities 51.49M 75.24M 50.5M 53.75M 49.71M
Total Debt 3.58M 4.88M 1.32M 5.06M 7.96M
Common Stock 1K 9K 7K 7K 4K
Retained Earnings -611.26M -441.43M -406.97M -377.17M -334.7M
Comprehensive Income n/a n/a n/a -0.00 n/a
Shareholders Equity 163.31M -8.21M -2.9M 21.57M 10.71M
Total Investments n/a n/a n/a n/a n/a